MiMedx Group, Inc. (MDXG)
4.59
-0.05
(-1.08%)
USD |
NASDAQ |
Oct 02, 16:00
4.59
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Profit Margin (Quarterly) : -23.06% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.06% |
| March 31, 2026 | -18.41% |
| December 31, 2025 | 12.86% |
| September 30, 2025 | 14.73% |
| June 30, 2025 | 9.75% |
| March 31, 2025 | 7.96% |
| December 31, 2024 | 8.01% |
| September 30, 2024 | 9.37% |
| June 30, 2024 | 20.21% |
| March 31, 2024 | 10.70% |
| December 31, 2023 | 59.06% |
| September 30, 2023 | 10.82% |
| June 30, 2023 | 11.38% |
| March 31, 2023 | -2.71% |
| December 31, 2022 | -0.56% |
| September 30, 2022 | -12.45% |
| June 30, 2022 | -16.25% |
| March 31, 2022 | -17.81% |
| December 31, 2021 | 3.29% |
| September 30, 2021 | -3.71% |
| June 30, 2021 | -2.61% |
| March 31, 2021 | -13.98% |
| December 31, 2020 | -24.19% |
| September 30, 2020 | -30.20% |
| June 30, 2020 | -15.78% |
| Date | Value |
|---|---|
| March 31, 2020 | -7.81% |
| December 31, 2019 | -9.79% |
| September 30, 2019 | 13.93% |
| June 30, 2019 | -25.52% |
| March 31, 2019 | -19.94% |
| December 31, 2018 | -39.12% |
| September 30, 2018 | -0.20% |
| June 30, 2018 | 1.89% |
| March 31, 2018 | 5.49% |
| December 31, 2017 | 39.83% |
| September 30, 2017 | 20.64% |
| June 30, 2017 | 10.56% |
| March 31, 2017 | 5.96% |
| December 31, 2016 | 7.84% |
| September 30, 2016 | 5.15% |
| June 30, 2016 | 3.44% |
| March 31, 2016 | 2.24% |
| December 31, 2015 | 25.81% |
| September 30, 2015 | 13.37% |
| June 30, 2015 | 11.89% |
| March 31, 2015 | 10.03% |
| December 31, 2014 | 9.68% |
| September 30, 2014 | 11.04% |
| June 30, 2014 | -1.53% |
| March 31, 2014 | -4.71% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Agenus, Inc. | -1.64% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.66% |
| Return on Assets | 2.02% |
| Return on Invested Capital | 2.47% |
| Gross Profit Margin (Quarterly) | 68.50% |
| Operating Margin (Quarterly) | -28.69% |
| Return on Net Operating Assets | 4.56% |